• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: Insulin degludec     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:WikicatRecombinantProteins, within Data Space : dbpedia.org associated with source document(s)

Type: Thingdul:ChemicalObjectchemical substancePill (pharmacy)yago:Abstraction100002137yago:Act100030358yago:Activity100407535yago:BodySubstance105263850yago:Care100654885yago:Chemical114806838yago:Compound114818238yago:Event100029378yago:Hormone105407119yago:LiquidBodySubstance105397468yago:Macromolecule114944888yago:Material114580897yago:Matter100020827yago:MedicalCare100657604yago:Molecule114682133yago:OrganicCompound114727670yago:Part113809207yago:PhysicalEntity100001930yago:Protein114728724yago:PsychologicalFeature100023100yago:RecombinantProtein114729633yago:Relation100031921yago:WikicatHumanProteinsyago:WikicatInsulinTherapiesyago:Work100575741yago:YagoPermanentlyLocatedEntitydrugyago:Secretion105404728yago:Substance100019613yago:Therapy100661091yago:Thing100002452yago:Treatment100658082yago:Unit109465459yago:WikicatPeptideHormonesyago:WikicatRecombinantProteins New Facet based on Instances of this Class

Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba. It is administered via subcutaneous injection once daily to help control the blood sugar level of those with diabetes. It has a duration of action that lasts up to 42 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir), making it a once-daily basal insulin, that is one that provides a base insulin level, as opposed to the fast- and short-acting bolus insulins.